Medimaps Group announces its participation in ECR 2024
Medimaps Group is thrilled to announce its participation in the European Congress of Radiology (ECR) 2024.
Join us to learn more about how TBS iNsight™ (Osteo) helps capture an additional ~30% of patients at risk of #fracture* in primary and secondary #osteoporosis. and discover the NEW TBS V4**.
📆 February 28 to March 02, 2024
📍 Booth AI-07, AI-Area, ECR (Vienna, Austria)
Seamlessly integrated into your current clinical workflow, TBS iNsight™ (Osteo) improves fracture risk prediction, helps identify more patients at risk of fracture and fine-tune therapy decision.
👉 Want to learn more? Receive a 15-minute demo of TBS iNsight™ (Osteo) or discover the potential of the new TBS iNsight™ (Osteo) V4**. You can schedule a meeting at ECR
Book a demo of TBS iNsight™ (Osteo) during this congress
*Adapted from Table 3 in Hans et al. J Bone Miner Res: 2011 Nov;26 (11):2762-9
**This product is currently under development and therefore cannot be yet commercially available. For more information, please contact your authorized Medimaps representative.